Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’
The Pharma Data
MAY 5, 2021
Roger Perlmutter, former Merck R&D head, becomes CEO of super-microscopy startup ( STAT ) ( Endpoints ). AbbVie’s Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along ( Fierce ). Merck KGaA raises forecast for full year 2021 ( Pharmaletter ).
Let's personalize your content